广州弗尔博生物科技有限公司 Company Information
Company Name:
Guangzhou Fu'erbo Biological Technology Co.,Ltd.
Tel:
-
Email:
1536198927@qq.com
Nationality:
China
WebSite:
www.chemicalbook.com/supplier/25444902/
Product List:
9315
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
Product List
Metabolic system
Screening model of gastrointestinal motility inhibitors
Myocardial injury protective agent screening model
Screening model of renal protective agents
Reproductive toxicity and reproductive ability evaluation; Gonadal growth evaluation; Histological sections of gonads;
Gastrointestinal peristalsis function (autonomic nerve).
inflammatory reaction
Intestinal morphology; Intestinal peristalsis requires motor function.
Animal long-term toxicity test
Drug stability test
Apoptosis inhibitor screening model
Fat metabolism model
Erythrocyte thrombosis model
Mouse bradycardia model
Incidence of developmental toxicity and teratogenicity (brain, jaw, eye, kidney, intestine, trunk / tail / spinal cord / somite, body coloring, circulatory system, body edema, bleeding)
Behavior (touch response, movement influence, light and dark influence);
Behavior
Anaphylactic reaction
neurotoxicity
Immunotoxicity
Preclinical drug experiment preclinical research (outsourcing entrusted experiment)
Efficacy evaluation model of drug efficacy evaluation system
Mitochondrial function
Protective model of vascular endothelial injury
Promoting tissue regeneration / wound healing
Embryotoxicity (OECD standard)
Degree of liver degeneration; Yolk sac size.
Osteotoxicity
Phenotypic observation
Induction model of high sugar and high fat diet
Screening model of antialcoholic agents
Screening model of angiogenesis promoters
Cytochrome P450 analysis
Cartilage injury model
apoptotic cell
The incidence of renal capsule edema;.
Ocular toxicity
Mortality; Evaluation of median lethal concentration (LC50).
Animal analgesic model
Animal modeling technology service
Screening model of P-glycoprotein inhibitors
Screening model of energy metabolism regulator
Induced qi stagnation and blood stasis thrombosis model
Liver kidney model
Cardiovascular toxicity heart rate; Heart rhythm; The incidence of pericardial edema; Incidence of bleeding; Incidence of changes in blood flow velocity; Incidence of thrombosis
Fluorescence signal intensity of apoptotic cells in central nervous system;
Carcinogenicity (mice)
Tryptase expression level (OD value); Anaphylactic reaction test.
Animal hybridization experiment
Preclinical evaluation of cardiac drugs
Anti angiogenesis model
Cardio cerebrovascular
PM2. 5. Screening model of drainage promoters
Screening model of bone development promoters
The incidence of egg coagulation; No heart rate; Hatching rate; The incidence of no somite formation; Incidence of tail non separation;
Nephrotoxicity
Bone mineral density (fluorescence signal intensity); Number of vertebrae.
Median lethal concentration
Skin irritation; Muscle texture; Quantification of skin apoptotic cells; Skin pigment changes.
Safety evaluation
Preclinical evaluation of antiviral research and development
Uric acid model
Intestinal digestive function
Skeletal muscle
Screening model of therapeutic agents for osteoporosis
Fluorescence signal intensity of apoptotic cells (AO staining, TUNEL staining)
Audiotoxicity
Eye size; Ocular apoptotic cells; Ocular vascular area; Ocular histopathology.
Genotoxicity
Modeling animal
Induction model of caspase activity
Pharmacodynamic evaluation model of slimming drugs
Drug screening model for the treatment of heart failure
Screening model of hepatoprotective drugs
Number of hematotoxic neutrophils; Number of macrophages; Number of red blood cells (signal intensity); Blood flow.
Peripheral motor nerve length; Incidence of brain degeneration;
Macrophage function
Gastrointestinal toxicity
Animal hemostatic model
Animal movement model
Preclinical spinal cord injury experiment
Angiogenesis inhibitor screening
Hypolipidemic model
Platelet aggregation thrombosis model
Oxygen free radical (ROS) scavenger screening model
Incidence of acute toxicity (brain, jaw, eye, kidney, intestine, trunk / tail / spinal cord / somite, body coloring, circulatory system, body edema, bleeding)
Vitellogenin (VTG) content detection; The expression of genes related to hypothalamic pituitary gonadal axis was detected.
Behavioral toxicity
Number of neutrophils; Expression level of inflammatory factors.
Drug evaluation and testing items (outsourcing entrusted experiment)
Preclinical evaluation of reproductive toxicity
Spleen yang deficiency model
Intestinal mucus secretion function
Analgesic drug screening
Drug safety evaluation model index
Hepatotoxicity (juvenile fish)
Fluorescence signal intensity of hair cells
Skin toxicity
Comet experiment; Genotoxicity evaluation.
Animal movement system model
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
Copyright 2007© ChemicalBook. All rights reserved.